[HTML][HTML] The how's and what's of vaccine reactogenicity

C Hervé, B Laupèze, G Del Giudice, AM Didierlaurent… - npj Vaccines, 2019 - nature.com
… In healthy adults that received the hepatitis B virus surface Antigen (HBsAg) combined with
different Adjuvant Systems (AS01, AS03, AS04 [MPL adsorbed onto aluminium hydroxide or …

[PDF][PDF] Retracted: Highlights From the European Respiratory Society Congress 2023: Chronic Obstructive Pulmonary Disease and Severe Asthma

E Roberts - emjreviews.com
… conjugate vaccine (PCV-13), or reduced antigen diphtheriatetanus-acellular pertussis vaccine
… a combination of an inhaled corticosteroid (ICS) and a long-acting β2-agonist (LABA) or a …

[HTML][HTML] Arthus reaction as an adverse event following Tdap vaccination

V Pool, L Mege, A Abou-Ali - Vaccines, 2020 - mdpi.com
… ) offering tetanus toxoid, tetanus toxoid adsorbed, and tetanus and diphtheria toxoid vaccines
… , VAERS Symptoms, and VAERS Vaccine) were merged to create a flat analytical dataset …

A phase-I, open label clinical trial to assess the safety of Tdap vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults

H Sharma, K Anil, S Parekh, P Pujari, S Shewale… - Vaccine, 2021 - Elsevier
… is formulated as a suspension of the antigens adsorbed on … Vaccination of adolescent
and adult population against pertussis using a reduced-antigen-content combined tetanus-…

Review of scientific evidence to support recommendations of the full-dose DTaP-IPV vaccination in pre-school age children in Italy

A Bechini, B Zanella, B Bonito, P Bonanni… - Expert Review of …, 2022 - Taylor & Francis
… Children at 4–6 years of age are scheduled to receive booster doses through combined
The administration of the fifth dose with a reduced antigen formulation in adolescence offers the …

[HTML][HTML] Diphtheria Tetanus Pertussis (DTaP) Vaccine

SA Ogden, JT Ludlow, K Alsayouri - 2019 - europepmc.org
… The DTaP vaccine is a combination vaccine against diphtheria, tetanus, and pertussis. It …
Safety Datalink (VSD) surveyed any adverse events with the acellular pertussis vaccine in the …

[HTML][HTML] Biomaterials-based formulations and surfaces to combat viral infectious diseases

S Kumari, K Chatterjee - APL bioengineering, 2021 - pubs.aip.org
Rapidly growing viral infections are potent risks to public health worldwide. Accessible virus-specific
antiviral vaccines and drugs are therapeutically inert to emerging viruses, such as …

Overcoming scientific barriers in the transition from in vivo to non-animal batch testing of human and veterinary vaccines

RHGA Van den Biggelaar, MHN Hoefnagel… - Expert Review of …, 2021 - Taylor & Francis
… possible and a combination of methods … reduced antigen content or a different composition,
by deviating from the standard inactivation method, or by changing the degree of adsorption

[HTML][HTML] IgG4 antibodies induced by repeated vaccination may generate immune tolerance to the SARS-CoV-2 spike protein

VN Uversky, EM Redwan, W Makis, A Rubio-Casillas - Vaccines, 2023 - mdpi.com
… It is interesting to note that two mRNA vaccines, together with one AZD1222 (AstraZeneca)
inoculation with an mRNA booster, and especially the mRNA-1273 vaccine, caused …

[HTML][HTML] Nonspecific Regulation of the Number of Immunocompetent Cells Under the Influence of DT Toxoid in Children With Glomerulonephritis

MP Kostinov, NK Akhmatova, OO Magarshak… - Frontiers in …, 2021 - frontiersin.org
adsorbed diphtheria-tetanus toxoid with a reduced antigen … A vaccination dose (0.5 mL)
contains 5 flocculating units (FU… against pertussis, since combined vaccines with an acellular